FDA Says Prostate Drugs Can Cause Cancer

Law360, New York (June 10, 2011, 3:32 PM EDT) -- The U.S. Food and Drug Administration on Thursday warned that several prescription drugs used to treat enlarged prostate glands and baldness could increase the risk of contracting an aggressive type of prostate cancer.

The FDA said it would add a new warning to the labels on Merck & Co. Inc.'s Proscar and Propecia and GlaxoSmithKline PLC's Avodart and Jalyn to alert doctors that the drugs elevate the risk of high-grade prostate cancer, which spreads faster than other forms of prostate cancer.

Avodart, Jalyn and Proscar are...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.